GIA
RMD icon

GHP Investment Advisors’s ResMed RMD Stock Holding History

GHP Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390 Hold
2
– – ﹤0.01% 1105
2026
Q1 		$449 Buy
+2
New +$498 ﹤0.01% 1117
2024
Q3 		– Sell
-46
Closed -$8.81K – 1058
2024
Q2 		$8.81K Buy
+46
New +$9.33K ﹤0.01% 707
2023
Q1 		– Sell
-54
Closed -$11.2K – 948
2022
Q4 		$11.2K Sell
54
-26
-33% -$5.71K ﹤0.01% 665
2022
Q3 		$17K Hold
80
– – ﹤0.01% 597
2022
Q2 		$17K Sell
80
-56
-41% -$11.9K ﹤0.01% 605
2022
Q1 		$33K Buy
+136
New +$32.9K ﹤0.01% 551

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GHP Investment Advisors's RMD Position: Q2 2026 in Review

GHP Investment Advisors held its ResMed (RMD) position steady in Q2 2026 at 2 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

GHP Investment Advisors first reported a position in RMD in Q1 2022 and has held it in 7 quarters since. The position peaked at $33K in Q1 2022. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • GHP Investment Advisors held 2 shares of ResMed worth $390 as of Q2 2026.
  • GHP Investment Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1105 holding.
  • GHP Investment Advisors first reported a position in ResMed in Q1 2022 and has held it in 7 quarters since.
  • GHP Investment Advisors's ResMed position peaked at $33K in Q1 2022.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.